Literature DB >> 25844265

Disseminated gonococcal infection presenting as bacteremia and liver abscesses in a healthy adult.

Min Hye Lee1, Jongkyu Byun1, Myounghwa Jung1, John Jeongseok Yang2, Ki-Ho Park1, Soo-Youn Moon1, Hee Joo Lee2, Mi Suk Lee1.   

Abstract

Herein, we describe a bacteremia caused by Neisseria gonorrhoeae that presented as liver abscesses. The patient had no risk factors for disseminated gonococcal infection. Periodic fever, skin rashes, and papules were present and the results of an abdominal computed tomography scan indicated the presence of small liver abscesses. The results of blood culture and 16S rRNA sequencing of the bacterial isolates confirmed the presence of N. gonorrhoeae. The patient improved with antibiotic therapy.

Entities:  

Keywords:  Disseminated gonococcal infection; Liver abscesses; Neisseria gonorrhoeae

Year:  2015        PMID: 25844265      PMCID: PMC4384456          DOI: 10.3947/ic.2015.47.1.60

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


Introduction

Gonorrhea is the second most commonly reported communicable disease in the United States, with an estimated incidence of more than 600,000 cases annually [1]. In Korea too, gonorrhea is the second most commonly reported sexually transmitted infection; 3,172 cases were registered by the Korean Centers for Disease Control & Prevention in 2007 [2]. Gonorrhea is usually characterized by cervicitis, urethritis, and pelvic inflammatory disease. Disseminated gonococcal infection (DGI) is an important mucosal infection caused by Neisseria gonorrhoeae but is rare. Classic DGI typically manifests as a combination of dermatitis, tenosynovitis, and migratory polyarthralgia, or as purulent arthritis without skin lesions. Endocarditis, meningitis, and osteomyelitis may also occur but are rare [3]. Here, we report an atypical manifestation of DGI presenting as bacteremia and liver abscesses along with a literature review.

Case Report

A 31-year-old man was admitted to the hospital with periodic fever, skin rashes, and papules on hands, feet, and lower legs as well as pain on the left ankle for the past 20 days. His past medical history was unremarkable. He had been on a business trip to Baengnyeong-do 3 months before admission and had traveled to Tongyeong 1 month before admission. He presented with fever and sore throat 1.5 months before admission and received medication. He did not show any urogenital symptoms such as dysuria or urinary frequency. He was single and heterosexual, and his last sexual contact was 3.5 months before admission. The day before admission, he had visited a dermatologist, at which time a punch biopsy specimen was obtained from a skin lesion on the left sole. On admission to the hospital, his body temperature was 38.3℃, blood pressure was 130/80 mmHg, pulse rate was 110 beats per minute, and respiratory rate was 20 breaths per minute. Upon physical examination, he seemed to be acutely ill with many hemorrhagic rashes and partly necrotic erythematous papules on both hands and feet (Fig. 1). His white blood cell count was 15,650/mm3 (neutrophil 84.0%), hemoglobin level was 11.5 g/dL, and platelet count was 81,000/ mm3. The erythrocyte sedimentation rate was 94 mm/hour, and C-reactive protein level increased to 8.23 mg/dL. The liver function test results were as follows: aspartate aminotransferase, 24 IU/L (normal range, <40 IU/L); alanine aminotransferase, 34 IU/L (normal range, <40 IU/L); gamma-glutamyl transpeptidase, 82 IU/L (normal range, <50 IU/L); total bilirubin, 0.68 mg/dL (normal range, 0.2-1.1 mg/dL); and direct bilirubin, 0.20 mg/dL (normal range, <0.5 mg/dL). The results of a human immunodeficiency virus antibody test and rapid plasma reagin test were negative. Similarly, hepatitis A, hepatitis B, and hepatitis C serology test results were negative. Chest radiography showed no active lung lesion. Blood, urine, and stool samples were collected for culture. The patient was treated with empirically intravenous ceftriaxone at a dose of 2 g once a day.
Figure 1

Skin examination results. (A) Many hemorrhagic rashes were noted on the foot. (B) Partly necrotic erythematous papule on the finger (black arrow).

On hospital day 2, for evaluation of the fever source, an abdominal computed tomography (CT) scan was performed and fever had subsided. The CT scan results indicated small-sized, low-attenuated lesions with enhancing wall in the liver, and these lesions were considered to be liver abscesses (Fig. 2). On hospital day 3, blood cultures revealed the presence of gram-negative diplococci. On hospital day 7, blood culture organisms were identified as N. gonorrhoeae using a conventional method. Sequencing of 16S rRNA of this isolate indicated the highest homology (99.9%) to the published sequence of N. gonorrhoeae strain NCTC 83785 (GenBank Accession No. NR-026079.1). This isolate was found to be intermediate-resistant to penicillin, resistant to ciprofloxacin and tetracycline, and susceptible to ceftriaxone, cefepime, and cefotaxime using the disk diffusion method.
Figure 2

Results of the abdominal computed tomography scan performed on admission indicated a small low-attenuated lesion with enhancing wall (white arrow) in the liver, suggesting a liver abscess. The size of the liver abscess was approximately 8 mm.

Histopathology examination of the skin biopsy indicated chronic dermatitis. C3 and C4 complement levels were 125 mg/dL (normal range, 88-201 mg/dL) and 20.6 mg/dL (normal range, 16-47 mg/dL), respectively. Follow-up blood culture was performed before discharge. After 8 days in the hospital, the patient's clinical status was better and he was discharged and prescribed oral cefixime 200 mg twice a day for 2 weeks. After 2 weeks, the patient visited the outpatient clinic of the infectious disease department. Follow-up blood cultures confirmed the absence of bacterial growth. However, he complained of sweating, pelvic pain, and mild fever (37.5℃); therefore, he was prescribed oral cefixime 200 mg twice a day for 1 week. Three weeks after hospital discharge, his symptoms were resolved and he no longer received antibiotic therapy. The follow-up abdominal CT scan examination after 4 weeks of therapy showed the absence of liver abscesses.

Discussion

DGI results from the bacteremic dissemination of N. gonorrhoeae and affects 1-3% of patients with gonorrhea [4,5,6,7,8,9,10]. In the Korean population, GDI is quite rare, and only 3 cases have been reported to date. In 2004, Kim et al. [11] reported a case of DGI concomitant with acute viral hepatitis C. Kim et al. [12] reported a case of DGI presenting as Sweet syndrome and Won et al. reported the first case of N. gonorrhoeae bacteremia in a 42-year-old man who had hepatitis B virus-associated liver cirrhosis with massive variceal hemorrhage [13] DGI is usually characterized by dermatitis, tenosynovitis, and septic arthritis and rarely by endocarditis, meningitis, and osteomyelitis [11]. The pathogenesis of DGI is associated with both microbial and host factors [14]. The host risk factors for DGI include female gender, pregnancy, menses, asymptomatic mucosal infection, multiple sexual partners, low socio-economic status, intravenous drug use, complement deficiency, HIV infection, and systemic lupus erythematosus [15, 16]. In addition, certain strains of N. gonorrhoeae (ex. Protein 1A serotype, those lacking protein II, and arginine-hypoxanthine-uracil strains) that are prone to cause disseminated infection differ biochemically from more common strains that cause urethral complications; in addition, they are less potent stimulators of inflammatory responses and are less likely to cause symptomatic urethral infections [15]. In this report, microbial factors may have had an important role in the development of DGI because the patient was immunocompetent and had no risk factors for DGI. However, we did not perform further phenotypic or serologic characterization of this isolate. The antimicrobial susceptibility of N. gonorrhoeae isolated from Korea in 2013 is shown in Table 1 [17].
Table 1

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates evaluated by disk diffusion [17]

Antimicrobial agents (Dosage)% of isolates with (N = 60)
SusceptibleIntermediateNot susceptibleResistant
Penicillin G (10 U)04258
Spectinomycin (100 g)10000
Ceftriaxone (0.5 µg)5050
Ceftriaxone (30 µg)7525
Cefixime (5 µg)7525
Cefpodoxime (10 µg)8218
Cefotaxime (30 µg)7030
Tetracycline (30 µg)0595
Ciprofloxacin (5 µg)5293
Nalidixic acid (30 µg)793
Azithromycin (15 µg)982
The incubation period of N. gonorrhoeae varies between 1 and 14 days (usually 2-5 days) [18], and hematogenous spread typically occurs within 2-3 weeks of the primary infection [19]. In the case reported herein, the patient's last sexual contact was 3.5 months before admission and symptoms included fever and sore throat approximately 2 months after the last sexual contact. Thus, the incubation period was long but the reason for the long incubation period was unknown. Patients with DGI usually have no urogenital symptoms but do have a history of past venereal infection. It was difficult to identify the causative agent of liver abscesses in this case because they were too small to drain. Therefore, the diagnosis was supported by the evaluation of sexual contact history, clinical symptoms, and bacteremia caused by N. gonorrhoeae. To the best of our knowledge, this is the first DGI case that presented as liver abscess complications. We performed a literature search to identify previously reported cases of liver abscess caused by N. gonorrhoeae but did not find any case. In general, DGI does not involve abdominal symptoms or signs, and therefore an abdominal CT scan was not necessary in the routine evaluation. Therefore, abdominal complications may occur in the rare cases of liver abscess caused by N. gonorrhoeae. In this regard, in Taiwan, Chung et al. [20] reported the case of a diabetic man with liver abscess due to N. sicca after repeated transcatheter arterial embolization for hepatocellular carcinoma. In summary, this is the first case of bacteremia with liver abscess caused by N. gonorrhoeae in a young healthy man who had no risk factors for DGI. The patient was successfully treated with 2 g of intravenous ceftriaxone daily for 1 week, followed by 200 mg of oral cefixime twice a day for 3 weeks. Further data will be needed to confirm the involvement of N. gonorrhoeae in the development of liver abscesses.
  15 in total

Review 1.  An overview of sexually transmitted diseases. Part I.

Authors:  T J Brown; A Yen-Moore; S K Tyring
Journal:  J Am Acad Dermatol       Date:  1999-10       Impact factor: 11.527

2.  The emerging threat of untreatable gonococcal infection.

Authors:  Gail A Bolan; P Frederick Sparling; Judith N Wasserheit
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

Review 3.  Cutaneous gonococcal infections.

Authors:  Samer H Ghosn; Abdul-Ghani Kibbi
Journal:  Clin Dermatol       Date:  2004 Nov-Dec       Impact factor: 3.541

4.  Disseminated gonococcal infection in an immunocompetent patient caused by an imported Neisseria gonorrhoeae multidrug-resistant strain.

Authors:  Ivano Dal Conte; Stefania Starnino; Giovanni Di Perri; Paola Stefanelli
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 5.  Disseminated gonococcal infection.

Authors:  K K Kerle; J R Mascola; T A Miller
Journal:  Am Fam Physician       Date:  1992-01       Impact factor: 3.292

6.  Disseminated gonococcal infection presenting as vasculitis: a case report.

Authors:  Sangita Jain; Htet Nwe Win; Venkat Chalam; Lian Yee
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

7.  Confirmation of association of protein I serotype of Neisseria gonorrhoeae with ability to cause disseminated infection.

Authors:  J G Cannon; T M Buchanan; P F Sparling
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  Gonococcemia associated with adult respiratory distress syndrome.

Authors:  M E Belding; J Carbone
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

9.  Disseminated gonococcal infections.

Authors:  S A Al-Suleiman; E M Grimes; H S Jonas
Journal:  Obstet Gynecol       Date:  1983-01       Impact factor: 7.661

10.  A case of bacteremia by Neisseria gonorrhoeae coincident with massive hemorrhage of esophageal varices.

Authors:  Dahae Won; Dongheui An; Mi-Na Kim; Young Sang Lee
Journal:  Korean J Lab Med       Date:  2011-04
View more
  6 in total

1.  4-Hydroxy-tetrahydrodipicolinate reductase from Neisseria gonorrhoeae - structure and interactions with coenzymes and substrate analog.

Authors:  Swanandi Pote; Sarah E Pye; Tyler E Sheahan; Anna Gawlicka-Chruszcz; Karolina A Majorek; Maksymilian Chruszcz
Journal:  Biochem Biophys Res Commun       Date:  2018-08-06       Impact factor: 3.575

2.  Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series.

Authors:  Page E Crew; Winston E Abara; Lynda McCulley; Peter E Waldron; Robert D Kirkcaldy; Emily J Weston; Kyle T Bernstein; S Christopher Jones; Susan J Bersoff-Matcha
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

3.  Disseminated gonococcal infection: an unusual presentation.

Authors:  Saroj Lohani; Salik Nazir; Niranjan Tachamo; Nitin Patel
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-07-06

4.  A Role of Sphingosine in the Intracellular Survival of Neisseria gonorrhoeae.

Authors:  Franziska Solger; Tobias C Kunz; Julian Fink; Kerstin Paprotka; Pauline Pfister; Franziska Hagen; Fabian Schumacher; Burkhard Kleuser; Jürgen Seibel; Thomas Rudel
Journal:  Front Cell Infect Microbiol       Date:  2020-05-12       Impact factor: 5.293

Review 5.  The Anti-Infectious Role of Sphingosine in Microbial Diseases.

Authors:  Yuqing Wu; Yongjie Liu; Erich Gulbins; Heike Grassmé
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

6.  Surface enhanced Raman spectroscopy of Chlamydia trachomatis and Neisseria gonorrhoeae for diagnostics, and extra-cellular metabolomics and biochemical monitoring.

Authors:  Y Chen; W R Premasiri; L D Ziegler
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.